syndrome	score	normalized_score
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	100.0
SPONDYLOPERIPHERAL DYSPLASIA	0.50204918	50.204918
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	50.0
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33702304	33.702304
PLACENTAL INSUFFICIENCY	0.333333	33.3333
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	33.3333
OROMANDIBULAR DYSTONIA	0.2500003	25.000030000000002
DYSTONIA 6, TORSION	0.25	25.0
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	25.0
HYPERPARATHYROIDISM 2	0.25	25.0
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.23976288	23.976288
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206101114	20.6101114
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	20.0545554
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20054555400000001	20.0545554
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	20.0
PFAPA SYNDROME	0.17543893000000002	17.543893
PEMPHIGUS VULGARIS	0.17071558	17.071558
WAARDENBURG SYNDROME	0.17035704000000002	17.035704000000003
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	16.666700000000002
SOLAR URTICARIA	0.166667	16.666700000000002
PHLEBECTASIA OF LIPS	0.166667	16.666700000000002
247150 LIP PRINTS	0.166667	16.666700000000002
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	16.666700000000002
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	16.666700000000002
XANTHOMA DISSEMINATUM	0.166667	16.666700000000002
PITYRIASIS RUBRA PILARIS	0.166667	16.666700000000002
ADNP SYNDROME	0.10039039999999999	10.03904
TRISOMY 8P	0.09690986	9.690986
CHRISTIANSON SYNDROME	0.09478929000000001	9.478929
ABLEPHARON-MACROSTOMIA SYNDROME	0.0940171	9.401710000000001
ERMINE PHENOTYPE	0.09234231000000001	9.234231000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09074071000000002	9.074071000000002
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.090013394	9.001339399999999
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08825229	8.825229
KBG SYNDROME	0.087251924	8.7251924
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	8.569503000000001
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08538248000000001	8.538248000000001
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08538078999999998	8.538078999999998
BECKWITH-WIEDEMANN SYNDROME	0.08450525	8.450525
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	8.333330000000002
ALKAPTONURIA	0.08333330000000001	8.333330000000002
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	8.333330000000002
SCLEROSTEOSIS	0.08333330000000001	8.333330000000002
DIPROSOPUS	0.08333330000000001	8.333330000000002
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08333330000000001	8.333330000000002
MUCKLE-WELLS SYNDROME	0.08333330000000001	8.333330000000002
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08250585	8.250585000000001
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.08024945	8.024945
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07820027	7.8200270000000005
CLARK-BARAITSER SYNDROME	0.07820026999999999	7.820026999999999
ATKIN-FLAITZ SYNDROME	0.07820026999999999	7.820026999999999
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	7.692310000000001
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	7.692310000000001
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	7.692310000000001
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.692310000000001
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.692310000000001
DDOST-CDG	0.07692310000000001	7.692310000000001
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	7.692310000000001
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	7.692310000000001
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	7.692310000000001
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.07521225399999999	7.5212254
SMITH-FINEMAN-MYERS SYNDROME	0.07407411	7.407411
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.07373067	7.373067
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.07090229399999999	7.090229399999999
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.07020027	7.020027
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.069261434	6.9261434
FRONTONASAL DYSPLASIA 1; FND1	0.06871588	6.871587999999999
KBG SYNDROME	0.067212254	6.7212254
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.067212254	6.7212254
COFS SYNDROME	0.06701159	6.701159
DIASTEMA, DENTAL MEDIAL	0.0666667	6.66667
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0666667	6.66667
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06371877999999999	6.371877999999999
MUCOLIPIDOSIS TYPE IV	0.05908917	5.908917000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.05891880000000001	5.8918800000000005
TRISOMY 9P	0.058150334	5.8150334
AREDYLD SYNDROME	0.05760478	5.760478
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.05760478	5.760478
TETRALOGY OF FALLOT	0.05760478	5.760478
DYSOSTOSIS, STANESCU TYPE	0.05760478	5.760478
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.05747746999999999	5.747746999999999
NON-DISTAL MONOSOMY 20Q	0.056256669999999995	5.625666999999999
3MC SYNDROME	0.055555600000000004	5.555560000000001
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.055555600000000004	5.555560000000001
POSTERIOR URETHRAL VALVE	0.055555600000000004	5.555560000000001
NAGER SYNDROME	0.055555600000000004	5.555560000000001
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.055555600000000004	5.555560000000001
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.055555600000000004	5.555560000000001
ANOPHTHALMIA PLUS SYNDROME	0.055555600000000004	5.555560000000001
CLASSICAL EHLERS-DANLOS SYNDROME	0.055555600000000004	5.555560000000001
CLEFT LIP AND ALVEOLUS	0.055555600000000004	5.555560000000001
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0548395	5.48395
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.053460549999999996	5.346055
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.053206790000000004	5.320679
AICARDI SYNDROME	0.05312268999999999	5.312269
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.052764149999999996	5.276414999999999
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.05114946	5.114946
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	5.059527
HAMAMY SYNDROME; HMMS	0.05059527	5.059527
HISTIDINEMIA	0.05043863	5.043863
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.049812060000000005	4.981206
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.049673023999999996	4.9673023999999995
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04867727000000001	4.867727000000001
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04817627000000001	4.817627000000001
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.04806555	4.8065549999999995
PGM3-CDG	0.04740591999999999	4.7405919999999995
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.047222259999999995	4.722225999999999
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.047222259999999995	4.722225999999999
LISSENCEPHALY, X-LINKED, 2	0.047170290000000004	4.717029
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.04601637	4.601637
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.04571528	4.571528
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04571528	4.571528
XP22.13P22.2 DUPLICATION SYNDROME	0.04535673999999999	4.535673999999999
49,XXXYY SYNDROME	0.04535673999999999	4.535673999999999
49,XYYYY SYNDROME	0.045200269999999994	4.520027
SLC39A8-CDG	0.04472331	4.4723310000000005
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.04471004	4.471004
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044017060000000004	4.401706000000001
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.043411370000000005	4.341137000000001
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04319908	4.319908
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04312171000000001	4.312171000000001
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	4.312171000000001
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.043028354	4.3028354
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.043028354	4.3028354
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042697094000000005	4.269709400000001
MOMO SYNDROME	0.0424828	4.24828
MARSHALL SYNDROME	0.0424828	4.24828
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0424828	4.24828
SHPRINTZEN OMPHALOCELE SYNDROME	0.04215154	4.215154
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.041842604000000005	4.1842604
XQ12-Q13.3 DUPLICATION SYNDROME	0.041666699999999994	4.166669999999999
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	4.166669999999999
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	4.166669999999999
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	4.166669999999999
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.041666699999999994	4.166669999999999
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	4.166669999999999
ACROCEPHALOPOLYDACTYLY	0.04051068	4.051068
MAL DE MELEDA	0.04051068	4.051068
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.040308434000000004	4.0308434
ZELLWEGER SYNDROME	0.03976288000000001	3.9762880000000007
SCHINZEL-GIEDION SYNDROME	0.039247870000000004	3.9247870000000002
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.038718393999999996	3.8718394
OGDEN SYNDROME; OGDNS	0.038561924	3.8561924
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.038561924	3.8561924
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	3.84615
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	3.84615
JUVENILE ABSENCE EPILEPSY	0.0384615	3.84615
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	3.84615
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	3.84615
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	3.84615
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	3.84615
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	3.84615
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	3.84615
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	3.84615
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	3.84615
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	3.84615
LIP, MEDIAN NODULE OF UPPER	0.0384615	3.84615
LIP, HAMARTOMATOUS	0.0384615	3.84615
JUVENILE MYOCLONIC EPILEPSY	0.0384615	3.84615
CYCLIC NEUTROPENIA	0.0384615	3.84615
BAZEX SYNDROME; BZX	0.0384615	3.84615
TETRASOMY 12P	0.03801637	3.801637
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03776348	3.776348
KEIPERT SYNDROME; KPTS	0.03653198	3.6531979999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03649369399999999	3.6493693999999994
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	3.6259854000000002
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	3.6259854000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	3.6259854000000002
COG1-CDG	0.035948139999999996	3.5948139999999995
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.035948139999999996	3.5948139999999995
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03579167	3.579167
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	3.5714300000000003
MICROHYDRANENCEPHALY; MHAC	0.035714300000000004	3.5714300000000003
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	3.5714300000000003
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	3.5714300000000003
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.035714300000000004	3.5714300000000003
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	3.5714300000000003
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	3.5714300000000003
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	3.5714300000000003
AMISH INFANTILE EPILEPSY SYNDROME	0.035714300000000004	3.5714300000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035028354	3.5028354
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.035028354	3.5028354
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.035028354	3.5028354
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0344828	3.44828
DIAMOND-BLACKFAN ANEMIA 8	0.0344828	3.44828
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0344828	3.44828
NASODIGITOACOUSTIC SYNDROME	0.0344828	3.44828
LATHOSTEROLOSIS	0.0344828	3.44828
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0344828	3.44828
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.034307279999999996	3.4307279999999993
OCULODENTODIGITAL DYSPLASIA	0.034307279999999996	3.4307279999999993
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	3.2803653999999995
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.032371934000000005	3.2371934000000007
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0322581	3.2258099999999996
ISOTRETINOIN-LIKE SYNDROME	0.0322581	3.2258099999999996
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	3.2258099999999996
DEND SYNDROME	0.0322581	3.2258099999999996
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	3.2258099999999996
SECKEL SYNDROME 2; SCKL2	0.0322581	3.2258099999999996
9P13 MICRODELETION SYNDROME	0.0322581	3.2258099999999996
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	3.2258099999999996
DENT DISEASE	0.0322581	3.2258099999999996
MILD CANAVAN DISEASE	0.0322581	3.2258099999999996
SECKEL SYNDROME	0.0322581	3.2258099999999996
CONGENITAL ANALBUMINEMIA	0.0322581	3.2258099999999996
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	3.2258099999999996
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	3.2258099999999996
DYSTONIA, JUVENILE-ONSET	0.0322581	3.2258099999999996
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	3.2258099999999996
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	3.2258099999999996
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0319766	3.19766
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.03157324	3.157324
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0305943	3.0594300000000003
TEMPLE-BARAITSER SYNDROME	0.03045544	3.045544
GABRIELE-DE VRIES SYNDROME	0.02997198	2.997198
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02989154	2.989154
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.029643810000000003	2.9643810000000004
MONOSOMY 18Q	0.029305614	2.9305614
DOORS SYNDROME	0.028745784000000003	2.8745784000000003
15Q13.3 MICRODELETION SYNDROME	0.028323354000000002	2.8323354000000003
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	2.8323354000000003
1Q41Q42 MICRODELETION SYNDROME	0.028116270000000002	2.811627
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	2.7777800000000004
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	2.7777800000000004
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	2.7777800000000004
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	2.7777800000000004
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	2.7777800000000004
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	2.7777800000000004
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	2.7777800000000004
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	2.7777800000000004
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	2.7777800000000004
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	2.7777800000000004
NASAL BONES, ABSENCE OF	0.027777800000000002	2.7777800000000004
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	2.7777800000000004
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	2.7777800000000004
CYANIDE, INABILITY TO SMELL	0.027777800000000002	2.7777800000000004
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	2.7777800000000004
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	2.7777800000000004
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	2.7777800000000004
OROFACIAL CLEFT 3	0.027777800000000002	2.7777800000000004
CLEFT CHIN	0.027777800000000002	2.7777800000000004
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	2.7777800000000004
DWARFISM, LEVI TYPE	0.027777800000000002	2.7777800000000004
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	2.7777800000000004
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	2.7777800000000004
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	2.7777800000000004
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	2.7777800000000004
DIMPLES, FACIAL	0.027777800000000002	2.7777800000000004
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	2.7777800000000004
MENKES DISEASE	0.027777800000000002	2.7777800000000004
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.026966614	2.6966614
CORNELIA DE LANGE SYNDROME 1	0.026709510000000002	2.670951
2Q23.1 MICRODUPLICATION SYNDROME	0.026221224	2.6221224000000003
COFFIN-SIRIS SYNDROME 2; CSS2	0.025239404	2.5239404
COFFIN-SIRIS SYNDROME 1; CSS1	0.025136713999999998	2.5136714
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.02507002	2.507002
COFFIN-LOWRY SYNDROME	0.02503874	2.503874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.02501155	2.5011550000000002
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.024355704	2.4355704
OCULOSKELETODENTAL SYNDROME; OCSKD	0.024118794	2.4118794
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.024088250000000002	2.408825
CORNELIA DE LANGE SYNDROME	0.024088250000000002	2.408825
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.024038694	2.4038694
6Q TERMINAL DELETION SYNDROME	0.023750054	2.3750054
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.02372971	2.372971
USHER SYNDROME	0.023501809999999998	2.3501809999999996
USHER SYNDROME TYPE 3	0.023501809999999998	2.3501809999999996
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.023501809999999998	2.3501809999999996
9Q33.3Q34.11 MICRODELETION SYNDROME	0.0233365	2.33365
CORNELIA DE LANGE SYNDROME 3	0.023309974	2.3309974
COFFIN-SIRIS SYNDROME 5	0.023190224000000002	2.3190224
NOONAN SYNDROME	0.02302633	2.302633
2Q31.1 MICRODELETION SYNDROME	0.022794964	2.2794964
TRISOMY 20P	0.02208885	2.208885
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.021491494	2.1491493999999998
PITT-HOPKINS SYNDROME	0.021491494	2.1491493999999998
TRISOMY 17P	0.021411054	2.1411054
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.02139352	2.1393519999999997
NOONAN SYNDROME 7; NS7	0.021380510000000002	2.1380510000000004
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.02116028	2.116028
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.021088134	2.1088134000000003
ENDOCARDIAL FIBROELASTOSIS	0.02093144	2.093144
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.020902254000000002	2.0902254
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02077497	2.077497
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.020665664	2.0665664
BARATELA-SCOTT SYNDROME	0.020532314	2.0532314
WHITE-SUTTON SYNDROME; WHSUS	0.020375674	2.0375674
MONOSOMY 18P	0.020295234000000002	2.0295234000000004
GORLIN-CHAUDHRY-MOSS SYNDROME	0.02012011	2.012011
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020060014	2.0060014
SCARF SYNDROME	0.020039670000000002	2.0039670000000003
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.020039670000000002	2.0039670000000003
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.020039670000000002	2.0039670000000003
FONTAINE PROGEROID SYNDROME; FPS	0.020039670000000002	2.0039670000000003
HADZISELIMOVIC SYNDROME	0.019656654000000003	1.9656654000000002
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.019656654000000003	1.9656654000000002
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.01951446	1.951446
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	1.9290580000000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.019138310000000002	1.9138310000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.019086934	1.9086934
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01897775	1.8977750000000002
DESANTO-SHINAWI SYNDROME	0.018643694	1.8643694
ALPHA-MANNOSIDOSIS	0.018571924	1.8571924
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018563084	1.8563084
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.01854572	1.854572
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.01854138	1.854138
MELAS	0.01854138	1.854138
WOLFRAM SYNDROME	0.01854138	1.854138
MAPLE SYRUP URINE DISEASE; MSUD	0.01854138	1.854138
RING CHROMOSOME 7 SYNDROME	0.018518510000000002	1.8518510000000001
WARBURG MICRO SYNDROME 2; WARBM2	0.018518510000000002	1.8518510000000001
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01817417	1.817417
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.018038044	1.8038044
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.017957924	1.7957924
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017957924	1.7957924
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.017877484	1.7877484
RECOMBINANT 8 SYNDROME	0.017877484	1.7877484
HALL-RIGGS SYNDROME	0.01785995	1.785995
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.017791154	1.7791154
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01749249	1.7492489999999998
RECOMBINANT CHROMOSOME 8 SYNDROME	0.017474124	1.7474124
16Q24.3 MICRODELETION SYNDROME	0.01741237	1.741237
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.017293184	1.7293184
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.72414
SICKLE CELL ANEMIA	0.0172414	1.72414
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.72414
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.72414
269800 SENILE PLAQUE FORMATION	0.0172414	1.72414
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.72414
TRANSSEXUALITY	0.0172414	1.72414
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.72414
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.72414
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.72414
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.72414
THUMBS, CONGENITAL CLASPED	0.0172414	1.72414
MYOPATHY, CONGENITAL	0.0172414	1.72414
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.72414
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.72414
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.72414
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.72414
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.72414
JUMPING FRENCHMAN OF MAINE	0.0172414	1.72414
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.72414
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.72414
ERYTHERMALGIA, PRIMARY	0.0172414	1.72414
RHEUMATOID ARTHRITIS	0.0172414	1.72414
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.72414
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.72414
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.72414
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.72414
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.72414
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.72414
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.72414
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.72414
PALMOMENTAL REFLEX	0.0172414	1.72414
MOSAIC TRISOMY 15	0.0172414	1.72414
MOTION SICKNESS	0.0172414	1.72414
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.72414
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.72414
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.72414
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.72414
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.72414
DIASTEMATOMYELIA	0.0172414	1.72414
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.72414
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.72414
ALCOHOL DEPENDENCE	0.0172414	1.72414
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.72414
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.72414
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.72414
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.72414
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.72414
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.72414
CARDIAC ARRHYTHMIA	0.0172414	1.72414
CERVICAL RIB	0.0172414	1.72414
ADAMS-OLIVER SYNDROME 2; AOS2	0.017212214	1.7212214
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.017212214	1.7212214
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.017212214	1.7212214
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.017212214	1.7212214
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.017159304	1.7159304
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01708913	1.7089130000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01708913	1.7089130000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.017078864	1.7078864
CARDIOFACIOCUTANEOUS SYNDROME	0.017056274	1.7056274
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.017056104	1.7056103999999999
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01703874	1.703874
SOTOS SYNDROME	0.016899634	1.6899634000000001
ACROOSTEOLYSIS DOMINANT TYPE	0.01669385	1.669385
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.01669385	1.669385
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.01666666	1.666666
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.016553654	1.6553654
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.01654198	1.654198
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.016510550000000002	1.6510550000000002
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01649654	1.649654
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01649654	1.649654
ZUNICH NEUROECTODERMAL SYNDROME	0.01640336	1.6403359999999998
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.016376670000000003	1.6376670000000002
COFFIN-SIRIS SYNDROME	0.016127704	1.6127704
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0160081	1.60081
MEHMO SYNDROME	0.015810770000000002	1.581077
LEPRECHAUNISM	0.015738620000000002	1.573862
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.015705234000000002	1.5705234000000001
COHEN SYNDROME	0.015705234000000002	1.5705234000000001
ACROMICRIC DYSPLASIA	0.01560474	1.5604740000000001
HENNEKAM-BEEMER SYNDROME	0.01540741	1.540741
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.015346694000000001	1.5346694
RABSON-MENDENHALL SYNDROME	0.015190224	1.5190224
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.015190224	1.5190224
SCHWARTZ-JAMPEL SYNDROME	0.015159680000000002	1.5159680000000002
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.015159680000000002	1.5159680000000002
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015110123999999999	1.5110123999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.015110123999999999	1.5110123999999998
DYSTONIA 28, CHILDHOOD-ONSET	0.015110123999999999	1.5110123999999998
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.015038354	1.5038354
1Q21.1 MICRODUPLICATION SYNDROME	0.015038354	1.5038354
HARTNUP DISEASE	0.015038354	1.5038354
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.015038354	1.5038354
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.015038354	1.5038354
CITRULLINEMIA TYPE II	0.015038354	1.5038354
USHER SYNDROME TYPE 1	0.015038354	1.5038354
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.015038354	1.5038354
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.015038354	1.5038354
PROLIDASE DEFICIENCY	0.01480114	1.4801140000000002
WITTEVEEN-KOLK SYNDROME	0.014643314000000001	1.4643314
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.014564569999999999	1.456457
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.014531664	1.4531664
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01451115	1.4511150000000002
GOLDBERG-SHPRINTZEN SYNDROME	0.014504474	1.4504474
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014504474	1.4504474
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.014504474	1.4504474
RING CHROMOSOME 22 SYNDROME	0.014504474	1.4504474
RIFT VALLEY FEVER	0.0144928	1.44928
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0144928	1.44928
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0144928	1.44928
PARKINSON DISEASE, LATE-ONSET; PD	0.0144928	1.44928
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0144928	1.44928
METACHROMATIC LEUKODYSTROPHY	0.0144928	1.44928
PORPHYRIA	0.0144928	1.44928
HUNTINGTON DISEASE-LIKE 2	0.0144928	1.44928
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0144928	1.44928
WOODHOUSE-SAKATI SYNDROME	0.0144928	1.44928
SCHIZOPHRENIA	0.0144928	1.44928
SCHIZOPHRENIA 1; SCZD1	0.0144928	1.44928
USHER SYNDROME TYPE 2	0.0144928	1.44928
CEREBROTENDINOUS XANTHOMATOSIS	0.0144928	1.44928
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	1.44928
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	1.44928
YOUNG-ONSET PARKINSON DISEASE	0.0144928	1.44928
MANGANESE POISONING	0.0144928	1.44928
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0144928	1.44928
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0144928	1.44928
INHERITED CREUTZFELDT-JAKOB DISEASE	0.0144928	1.44928
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0144928	1.44928
RABIES	0.0144928	1.44928
NARCOLEPSY TYPE 1	0.0144928	1.44928
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.0144928	1.44928
KUFOR-RAKEB SYNDROME	0.0144928	1.44928
FAMILIAL COLORECTAL CANCER TYPE X	0.0144928	1.44928
ACUTE INTERMITTENT PORPHYRIA	0.0144928	1.44928
NARCOLEPSY TYPE 2	0.0144928	1.44928
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0144928	1.44928
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0144928	1.44928
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.0144928	1.44928
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.0144928	1.44928
SCHIZOPHRENIA 10	0.0144928	1.44928
LEGIONELLOSIS	0.0144928	1.44928
CREUTZFELDT-JAKOB DISEASE; CJD	0.0144928	1.44928
NORRIE DISEASE	0.0144928	1.44928
CARIBBEAN PARKINSONISM	0.0144928	1.44928
LYNCH SYNDROME	0.0144928	1.44928
WOODHOUSE-SAKATI SYNDROME	0.0144928	1.44928
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.0144928	1.44928
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	1.44928
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0144928	1.44928
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.0144928	1.44928
17Q24.2 MICRODELETION SYNDROME	0.0144928	1.44928
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	1.44928
3Q27.3 MICRODELETION SYNDROME	0.0144928	1.44928
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.014484130000000001	1.4484130000000002
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.014484130000000001	1.4484130000000002
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.014484130000000001	1.4484130000000002
KAPUR-TORIELLO SYNDROME	0.014484130000000001	1.4484130000000002
TEMTAMY SYNDROME	0.014128304	1.4128304
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.014101114000000001	1.4101114000000001
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.014101114000000001	1.4101114000000001
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.01409776	1.4097760000000001
FRANK-TER HAAR SYNDROME	0.01398611	1.398611
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01398611	1.398611
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.01395892	1.395892
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013705834	1.3705834000000001
MUENKE SYNDROME	0.013705834	1.3705834000000001
KOOLEN-DE VRIES SYNDROME	0.013683264	1.3683264
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013603144000000001	1.3603144
CARPENTER-WAZIRI SYNDROME	0.013582750000000001	1.3582750000000001
MACS SYNDROME	0.01358275	1.358275
FOUNTAIN SYNDROME	0.01358275	1.358275
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.013555560000000001	1.3555560000000002
ACROMICRIC DYSPLASIA	0.013555560000000001	1.3555560000000002
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013508524000000001	1.3508524000000002
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.013508524000000001	1.3508524000000002
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013244604	1.3244604
EPIDERMAL NEVUS SYNDROME	0.013244604	1.3244604
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.013244604	1.3244604
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.013244604	1.3244604
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.013244604	1.3244604
MENTAL RETARDATION, X-LINKED 91; MRX91	0.013164163999999999	1.3164163999999998
DUBOWITZ SYNDROME	0.01316028	1.316028
SAETHRE-CHOTZEN SYNDROME	0.01316028	1.316028
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.01314663	1.314663
CONO-SPONDYLAR DYSPLASIA	0.01314663	1.314663
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01313771	1.313771
TRICHOTHIODYSTROPHY	0.013088134	1.3088134
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.013088134	1.3088134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.013088134	1.3088134
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01305759	1.3057590000000001
STICKLER SYNDROME	0.01305759	1.3057590000000001
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.013007694	1.3007694
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.013007694	1.3007694
X SMALL RINGS	0.013007694	1.3007694
JOUBERT SYNDROME 10	0.012997494000000002	1.2997494000000003
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01299016	1.299016
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.01297715	1.297715
MALAN OVERGROWTH SYNDROME	0.01297715	1.297715
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.01296297	1.296297
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012851054	1.2851054
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.01282051	1.282051
FAMILIAL DYSAUTONOMIA	0.01282051	1.282051
CAFFEY DISEASE	0.01282051	1.282051
2Q33.1 DELETION SYNDROME	0.01282051	1.282051
MENKES DISEASE	0.01282051	1.282051
SCLERODERMA	0.01282051	1.282051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012638954	1.2638954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.012638954	1.2638954
NOONAN SYNDROME 5; NS5	0.012638954	1.2638954
48,XXYY SYNDROME	0.012594134	1.2594134
PITT-HOPKINS SYNDROME	0.01254258	1.2542579999999999
SIFRIM-HITZ-WEISS SYNDROME	0.01254258	1.2542579999999999
MUCOPOLYSACCHARIDOSIS TYPE 2	0.012482484	1.2482484
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012482484	1.2482484
PETTIGREW SYNDROME	0.012482484	1.2482484
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.012482484	1.2482484
HURLER SYNDROME	0.012482484	1.2482484
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.012482484	1.2482484
HURLER SYNDROME	0.012482484	1.2482484
SCARF SYNDROME	0.01246214	1.246214
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.01246214	1.246214
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.01246214	1.246214
MILROY DISEASE	0.012461970000000001	1.246197
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.012451940000000002	1.2451940000000001
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.012451940000000002	1.2451940000000001
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.012235594	1.2235594
FLOATING-HARBOR SYNDROME	0.012198874000000002	1.2198874000000002
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0120934	1.20934
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0120934	1.20934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0120934	1.20934
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0120934	1.20934
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.012079124	1.2079124
COSTELLO SYNDROME; CSTLO	0.012079124	1.2079124
HELSMOORTEL-VAN DER AA SYNDROME	0.012079124	1.2079124
CRI-DU-CHAT SYNDROME	0.01204858	1.204858
MEIER-GORLIN SYNDROME 1; MGORS1	0.01204858	1.204858
WILLIAMS-BEUREN SYNDROME; WBS	0.01204858	1.204858
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.01193693	1.1936930000000001
ASPARTYLGLUCOSAMINURIA	0.01193693	1.1936930000000001
ATKIN-FLAITZ SYNDROME	0.01193693	1.1936930000000001
SCHEIE SYNDROME	0.01193693	1.1936930000000001
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01193693	1.1936930000000001
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01169004	1.1690040000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.011683864	1.1683864
BOHRING-OPITZ SYNDROME	0.011656654	1.1656654
CRANIOSYNOSTOSIS 6; CRS6	0.011656654	1.1656654
MACDERMOT-WINTER SYNDROME	0.011656654	1.1656654
TYSHCHENKO SYNDROME	0.011656654	1.1656654
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.011656654	1.1656654
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011656654	1.1656654
TREACHER-COLLINS SYNDROME	0.011656654	1.1656654
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.011656654	1.1656654
ALAZAMI-YUAN SYNDROME	0.011656654	1.1656654
LIG4 SYNDROME	0.011656654	1.1656654
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.011656654	1.1656654
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.011656654	1.1656654
DISTAL 16P11.2 MICRODELETION SYNDROME	0.011656654	1.1656654
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.011656654	1.1656654
BOHRING-OPITZ SYNDROME	0.011656654	1.1656654
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.011656654	1.1656654
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011603744	1.1603743999999998
DISTAL MONOSOMY 10Q	0.011603744	1.1603743999999998
BARDET-BIEDL SYNDROME 1; BBS1	0.011603744	1.1603743999999998
MOSAIC TRISOMY 1	0.01153357	1.153357
WILLIAMS SYNDROME	0.01153357	1.153357
MUCOPOLYSACCHARIDOSIS, TYPE II	0.01153357	1.153357
COSTELLO SYNDROME	0.01153357	1.153357
MUCOPOLYSACCHARIDOSIS TYPE 6	0.01153357	1.153357
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01153357	1.153357
ASPARTYLGLUCOSAMINURIA; AGU	0.01153357	1.153357
FOUNTAIN SYNDROME	0.01153357	1.153357
SOMATOMAMMOTROPINOMA	0.01153357	1.153357
ACROMEGALY	0.01153357	1.153357
FABRY DISEASE	0.01153357	1.153357
SIALIDOSIS TYPE 1	0.01153357	1.153357
ZIMMERMANN-LABAND SYNDROME 1	0.01153357	1.153357
DUANE RETRACTION SYNDROME	0.011523304	1.1523304
CRANIOFRONTONASAL SYNDROME; CFNS	0.011523304	1.1523304
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.011486534	1.1486534
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.01145599	1.1455989999999998
ALLAN-HERNDON-DUDLEY SYNDROME	0.01145599	1.1455989999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.01145599	1.1455989999999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01145599	1.1455989999999998
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.01145599	1.1455989999999998
BOWEN-CONRADI SYNDROME	0.01145599	1.1455989999999998
MYHRE SYNDROME	0.011366664	1.1366664
20Q11.2 MICRODELETION SYNDROME	0.011366664	1.1366664
TONNE-KALSCHEUER SYNDROME; TOKAS	0.011366664	1.1366664
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01113831	1.113831
16P12.1P12.3 TRIPLICATION SYNDROME	0.01113831	1.113831
TRISOMY 4P	0.0111111	1.11111
TEEBI-SHALTOUT SYNDROME; TBSH	0.0111111	1.11111
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0111111	1.11111
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0111111	1.11111
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0111111	1.11111
NIJMEGEN BREAKAGE SYNDROME	0.0111111	1.11111
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0111111	1.11111
WARBURG MICRO SYNDROME 3; WARBM3	0.0111111	1.11111
CHROMOSOME 18Q DELETION SYNDROME	0.0111111	1.11111
UNILATERAL POLYMICROGYRIA	0.01109745	1.109745
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01109745	1.109745
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	1.109745
PITT-HOPKINS-LIKE SYNDROME	0.01109745	1.109745
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.01109745	1.109745
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.011058189999999999	1.1058189999999999
LOWRY-WOOD SYNDROME	0.011058189999999999	1.1058189999999999
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.010998094	1.0998094
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010998094	1.0998094
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01097775	1.097775
EMERY-NELSON SYNDROME	0.01097775	1.097775
HEART-HAND SYNDROME TYPE 2	0.01097775	1.097775
CRANIOFRONTONASAL DYSPLASIA	0.01097775	1.097775
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.01097775	1.097775
PELVISCAPULAR DYSPLASIA	0.01097775	1.097775
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.01097775	1.097775
FRYNS SYNDROME	0.01094098	1.094098
MUCOLIPIDOSIS TYPE II	0.01094098	1.094098
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.01094098	1.094098
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.010594734	1.0594734
ELSAHY-WATERS SYNDROME; ESWS	0.010594734	1.0594734
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01045254	1.045254
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.01045254	1.045254
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.01045254	1.045254
CHITAYAT SYNDROME	0.01045254	1.045254
HOLOPROSENCEPHALY	0.010333354	1.0333354
22Q11.2 DELETION SYNDROME	0.010149694	1.0149694
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.010149694	1.0149694
KOOLEN-DE VRIES SYNDROME; KDVS	0.010149694	1.0149694
DOWN SYNDROME	0.01004918	1.004918
COFFIN-SIRIS SYNDROME 6; CSS6	0.009818344	0.9818344
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009791154	0.9791154
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.009791154	0.9791154
OROFACIODIGITAL SYNDROME TYPE 14	0.009791154	0.9791154
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.009791154	0.9791154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0097878	0.97878
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009634684000000001	0.9634684000000001
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.009634684000000001	0.9634684000000001
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009634684000000001	0.9634684000000001
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.009634684000000001	0.9634684000000001
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009634684000000001	0.9634684000000001
DISTAL MONOSOMY 12Q	0.009634684000000001	0.9634684000000001
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.009554564	0.9554564
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.009554564	0.9554564
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009554564	0.9554564
EMANUEL SYNDROME	0.009554564	0.9554564
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.009554564	0.9554564
FANCONI ANEMIA	0.009554564	0.9554564
1P21.3 MICRODELETION SYNDROME	0.009554564	0.9554564
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009554564	0.9554564
OCULOECTODERMAL SYNDROME; OES	0.009554564	0.9554564
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.009554564	0.9554564
RAHMAN SYNDROME	0.009554564	0.9554564
OKAMOTO SYNDROME	0.009554564	0.9554564
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.009554564	0.9554564
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009554564	0.9554564
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.9554564
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.009554564	0.9554564
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009554564	0.9554564
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009554564	0.9554564
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009554564	0.9554564
FETAL HYDANTOIN SYNDROME	0.009474124	0.9474124
RITSCHER-SCHINZEL SYNDROME 1	0.009474124	0.9474124
DISTAL TRISOMY 17Q	0.009474124	0.9474124
WOLF-HIRSCHHORN SYNDROME	0.009474124	0.9474124
CHROMOSOME 10Q26 DELETION SYNDROME	0.009474124	0.9474124
LATERAL MENINGOCELE SYNDROME	0.009474124	0.9474124
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009474124	0.9474124
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.009474124	0.9474124
MONOSOMY 9P	0.009474124	0.9474124
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009474124	0.9474124
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009456589999999999	0.9456589999999999
WEAVER SYNDROME	0.009317484000000001	0.9317484
ARGININEMIA	0.009317484000000001	0.9317484
LANDAU-KLEFFNER SYNDROME	0.009317484000000001	0.9317484
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.9317484
MENTAL RETARDATION, X-LINKED 90	0.009317484000000001	0.9317484
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.9317484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.9317484
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.9317484
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.9317484
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.9317484
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.9317484
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.9317484
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009317484000000001	0.9317484
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009317484000000001	0.9317484
INFANTILE REFSUM DISEASE	0.009317484000000001	0.9317484
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.9317484
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.9317484
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.9317484
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.9317484
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0092456	0.9245599999999999
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0092456	0.9245599999999999
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00908913	0.9089130000000001
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00908913	0.9089130000000001
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.00908913	0.9089130000000001
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.900901
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00900901	0.900901
HERMANSKY-PUDLAK SYNDROME	0.00900901	0.900901
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00900901	0.900901
NEUROTROPHIC KERATOPATHY	0.00900901	0.900901
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00900901	0.900901
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00900901	0.900901
7Q11.23 MICRODUPLICATION SYNDROME	0.00900901	0.900901
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00900901	0.900901
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00900901	0.900901
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.900901
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00900901	0.900901
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00900901	0.900901
OCULAR ALBINISM	0.00900901	0.900901
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.900901
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00900901	0.900901
RETINAL CONE DYSTROPHY 3B	0.00900901	0.900901
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00900901	0.900901
MEGALOCORNEA	0.00900901	0.900901
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.00900901	0.900901
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00900901	0.900901
ALAND ISLAND EYE DISEASE	0.00900901	0.900901
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00900901	0.900901
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.900901
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.900901
SANJAD-SAKATI SYNDROME	0.00900901	0.900901
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00900901	0.900901
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.900901
OCULOCUTANEOUS ALBINISM	0.00900901	0.900901
X-LINKED RECESSIVE OCULAR ALBINISM	0.00900901	0.900901
ÅLAND ISLANDS EYE DISEASE	0.00900901	0.900901
SOTOS SYNDROME 2	0.00900901	0.900901
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00900901	0.900901
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.900901
EDICT SYNDROME	0.00900901	0.900901
POPOV-CHANG SYNDROME; POPCHAS	0.008948914	0.8948914
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.008948914	0.8948914
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008948914	0.8948914
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.008948914	0.8948914
EAR-PATELLA-SHORT STATURE SYNDROME	0.008948914	0.8948914
TEMPLE-BARAITSER SYNDROME; TMBTS	0.008948914	0.8948914
ALAZAMI SYNDROME; ALAZS	0.008948914	0.8948914
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.008948914	0.8948914
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.008948914	0.8948914
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.008948914	0.8948914
THAUVIN-ROBINET-FAIVRE SYNDROME	0.008948914	0.8948914
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.008948914	0.8948914
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.008948914	0.8948914
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.008948914	0.8948914
8P23.1 DUPLICATION SYNDROME	0.008948914	0.8948914
CHAR SYNDROME	0.008948914	0.8948914
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.008948914	0.8948914
MAN1B1-CDG	0.008948914	0.8948914
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.008948914	0.8948914
XQ25 DUPLICATION SYNDROME	0.008948914	0.8948914
19P13.3 MICRODUPLICATION SYNDROME	0.008948914	0.8948914
FG SYNDROME TYPE 1	0.008948914	0.8948914
XQ25 MICRODUPLICATION SYNDROME	0.008948914	0.8948914
MOSAIC MONOSOMY X	0.00892857	0.892857
ISOLATED KLIPPEL-FEIL SYNDROME	0.00892857	0.892857
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00892857	0.892857
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00892857	0.892857
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00892857	0.892857
FLOATING-HARBOR SYNDROME	0.00892857	0.892857
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00892857	0.892857
RING CHROMOSOME 8 SYNDROME	0.00892857	0.892857
WILDERVANCK SYNDROME	0.00892857	0.892857
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.892857
SPONDYLO-OCULAR SYNDROME	0.00892857	0.892857
MONOSOMY X	0.00892857	0.892857
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00892857	0.892857
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.892857
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.892857
JUNG SYNDROME	0.00892857	0.892857
CEREBROFACIOTHORACIC DYSPLASIA	0.00892857	0.892857
BRANCHIOOCULOFACIAL SYNDROME	0.00892857	0.892857
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.892857
LEGIUS SYNDROME	0.00892857	0.892857
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00892857	0.892857
RING CHROMOSOME 6 SYNDROME	0.00892857	0.892857
SPONDYLOOCULAR SYNDROME; SOS	0.00892857	0.892857
POLAND SYNDROME	0.00892857	0.892857
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.892857
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.892857
TURNER SYNDROME	0.00892857	0.892857
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00892857	0.892857
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00892857	0.892857
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00892857	0.892857
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.892857
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00892857	0.892857
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.892857
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00892857	0.892857
THORACOMELIC DYSPLASIA	0.00892857	0.892857
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00892857	0.892857
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.892857
EDINBURGH MALFORMATION SYNDROME	0.00892857	0.892857
PTERYGIUM COLLI, ISOLATED	0.00892857	0.892857
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.8771930000000001
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.8771930000000001
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.8771930000000001
SNEDDON SYNDROME	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.8771930000000001
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8771930000000001
HUNTINGTON DISEASE	0.00877193	0.8771930000000001
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.8771930000000001
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.8771930000000001
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.8771930000000001
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.8771930000000001
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.8771930000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.8771930000000001
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.8771930000000001
DIENCEPHALIC SYNDROME	0.00877193	0.8771930000000001
HISTIDINEMIA	0.00877193	0.8771930000000001
NEUROFERRITINOPATHY	0.00877193	0.8771930000000001
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.8771930000000001
LOCKED-IN SYNDROME	0.00877193	0.8771930000000001
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.8771930000000001
ANGELMAN SYNDROME	0.00877193	0.8771930000000001
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.8771930000000001
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.8771930000000001
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.8771930000000001
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.8771930000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.8771930000000001
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8771930000000001
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.8771930000000001
PINEOBLASTOMA	0.00877193	0.8771930000000001
NANCE-HORAN SYNDROME	0.00877193	0.8771930000000001
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.8771930000000001
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.8771930000000001
CORTICOBASAL SYNDROME	0.00877193	0.8771930000000001
CRYPTOCOCCOSIS	0.00877193	0.8771930000000001
BREATH-HOLDING SPELLS	0.00877193	0.8771930000000001
LESCH-NYHAN SYNDROME	0.00877193	0.8771930000000001
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.8771930000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.8771930000000001
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.8771930000000001
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.8771930000000001
RHEUMATIC FEVER	0.00877193	0.8771930000000001
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.8771930000000001
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.8771930000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.8771930000000001
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.8771930000000001
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	0.8771930000000001
PELIZAEUS-MERZBACHER DISEASE	0.00877193	0.8771930000000001
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.8771930000000001
KEIPERT SYNDROME	0.00877193	0.8771930000000001
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.8771930000000001
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.8771930000000001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.008545554	0.8545554000000001
48,XYYY SYNDROME	0.008545554	0.8545554000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.008545554	0.8545554000000001
GABRIELE-DE VRIES SYNDROME; GADEVS	0.008545554	0.8545554000000001
HEART AND BRAIN MALFORMATION SYNDROME	0.008545554	0.8545554000000001
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008545554	0.8545554000000001
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.008545554	0.8545554000000001
15Q24 MICRODELETION SYNDROME	0.008545554	0.8545554000000001
MENTAL RETARDATION, X-LINKED 9	0.008545554	0.8545554000000001
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00840336	0.8403360000000001
FEINGOLD SYNDROME 1; FGLDS1	0.00840336	0.8403360000000001
THREE M SYNDROME 2; 3M2	0.00840336	0.8403360000000001
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00840336	0.8403360000000001
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00840336	0.8403360000000001
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00840336	0.8403360000000001
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00840336	0.8403360000000001
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00840336	0.8403360000000001
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00840336	0.8403360000000001
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00840336	0.8403360000000001
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00840336	0.8403360000000001
FRAXE INTELLECTUAL DISABILITY	0.00840336	0.8403360000000001
ATYPICAL RETT SYNDROME	0.00840336	0.8403360000000001
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00840336	0.8403360000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00840336	0.8403360000000001
SPONASTRIME DYSPLASIA	0.00840336	0.8403360000000001
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00840336	0.8403360000000001
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00840336	0.8403360000000001
HURLER-SCHEIE SYNDROME	0.00840336	0.8403360000000001
MEIER-GORLIN SYNDROME 8; MGORS8	0.00840336	0.8403360000000001
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00840336	0.8403360000000001
CHIME SYNDROME	0.00840336	0.8403360000000001
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00840336	0.8403360000000001
MEIER-GORLIN SYNDROME 6; MGORS6	0.00840336	0.8403360000000001
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00840336	0.8403360000000001
NEU-LAXOVA SYNDROME	0.00840336	0.8403360000000001
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00840336	0.8403360000000001
XYLT1-CDG	0.00840336	0.8403360000000001
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00840336	0.8403360000000001
CHROMOSOME 16P13.3 DELETION SYNDROME	0.008284174	0.8284174
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008284174	0.8284174
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.008284174	0.8284174
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.008150294	0.8150294
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.008150294	0.8150294
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.008150294	0.8150294
CONGENITAL HYPOTHYROIDISM	0.008127704	0.8127704
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.008127704	0.8127704
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008127704	0.8127704
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008	0.8
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.008	0.8
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008	0.8
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008	0.8
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.008	0.8
PROGNATHISM, MANDIBULAR	0.008	0.8
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.008	0.8
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.008	0.8
MEIER-GORLIN SYNDROME 3; MGORS3	0.008	0.8
FRYNS-SMEETS-THIRY SYNDROME	0.008	0.8
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.008	0.8
PRIMROSE SYNDROME; PRIMS	0.008	0.8
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.008	0.8
NAKAJO-NISHIMURA SYNDROME	0.008	0.8
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.008	0.8
NOONAN SYNDROME 4; NS4	0.008	0.8
LIPOID PROTEINOSIS	0.008	0.8
HYPERCALCEMIA, INFANTILE, 1	0.008	0.8
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.008	0.8
MENTAL RETARDATION, X-LINKED 19	0.008	0.8
COFFIN-SIRIS SYNDROME 8; CSS8	0.008	0.8
CHEILITIS GLANDULARIS	0.008	0.8
BLACKFAN-DIAMOND ANEMIA	0.008	0.8
GAPO SYNDROME; GAPOS	0.008	0.8
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.008	0.8
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.008	0.8
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.7952964
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.7952964
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.7952964
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.007952964	0.7952964
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.7952964
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.7952964
PIERPONT SYNDROME	0.007952964	0.7952964
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.7952964
ADENYLOSUCCINASE DEFICIENCY	0.007952964	0.7952964
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007952964	0.7952964
300270 ADRENOMYODYSTROPHY	0.007952964	0.7952964
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00773862	0.7738619999999999
CAMURATI-ENGELMANN DISEASE	0.00773862	0.7738619999999999
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00773862	0.7738619999999999
ESOPHAGEAL ATRESIA	0.00773862	0.7738619999999999
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0076047400000000005	0.7604740000000001
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0076047400000000005	0.7604740000000001
15Q26 OVERGROWTH SYNDROME	0.0076047400000000005	0.7604740000000001
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0076047400000000005	0.7604740000000001
MESOMELIA-SYNOSTOSES SYNDROME	0.0076047400000000005	0.7604740000000001
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.007582150000000001	0.7582150000000001
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.740741
YUNIS-VARON SYNDROME	0.00740741	0.740741
TRISOMY XQ28	0.00740741	0.740741
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00740741	0.740741
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.740741
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.740741
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.740741
KID SYNDROME	0.00740741	0.740741
DPM1-CDG	0.00740741	0.740741
TRISOMY 13	0.00740741	0.740741
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.740741
SECKEL SYNDROME 7; SCKL7	0.00740741	0.740741
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.740741
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00740741	0.740741
ADRENOMYODYSTROPHY	0.00740741	0.740741
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.740741
COG8-CDG	0.00740741	0.740741
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.740741
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.740741
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.740741
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.740741
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.740741
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.740741
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.740741
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.740741
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.740741
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.740741
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.740741
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00740741	0.740741
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.740741
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.740741
AMISH LETHAL MICROCEPHALY	0.00740741	0.740741
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00740741	0.740741
2Q24 MICRODELETION SYNDROME	0.00740741	0.740741
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.740741
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.740741
KEPPEN-LUBINSKY SYNDROME	0.00740741	0.740741
DISTAL MONOSOMY 10P	0.00740741	0.740741
LOWRY-MACLEAN SYNDROME	0.00740741	0.740741
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.740741
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00740741	0.740741
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.740741
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.740741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.740741
4Q21 MICRODELETION SYNDROME	0.00740741	0.740741
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.740741
CROME SYNDROME	0.00740741	0.740741
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.740741
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.740741
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00740741	0.740741
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.740741
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.740741
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.740741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.740741
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.740741
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.740741
MONOSOMY 5P	0.00740741	0.740741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.740741
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.740741
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.740741
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.740741
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00740741	0.740741
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.740741
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.740741
LISSENCEPHALY 5; LIS5	0.00740741	0.740741
OROFACIODIGITAL SYNDROME TYPE 6	0.006643314	0.6643314
PETERS PLUS SYNDROME	0.006643314	0.6643314
RUBINSTEIN-TAYBI SYNDROME	0.006643314	0.6643314
SMITH-LEMLI-OPITZ SYNDROME	0.006643314	0.6643314
1P36 DELETION SYNDROME	0.006643314	0.6643314
3C SYNDROME	0.006643314	0.6643314
CHARGE SYNDROME	0.006643314	0.6643314
CHROMOSOME 1P36 DELETION SYNDROME	0.006643314	0.6643314
PETERS-PLUS SYNDROME; PTRPLS	0.006643314	0.6643314
SMITH-MAGENIS SYNDROME	0.006643314	0.6643314
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006284774	0.6284774
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.006284774	0.6284774
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006284774	0.6284774
MATERNAL PHENYLKETONURIA	0.006284774	0.6284774
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.006284774	0.6284774
CHOPS SYNDROME; CHOPS	0.006128303999999999	0.6128303999999999
COFFIN-SIRIS SYNDROME 7; CSS7	0.006128303999999999	0.6128303999999999
GENITOPATELLAR SYNDROME; GTPTS	0.006128303999999999	0.6128303999999999
SCHAAF-YANG SYNDROME; SHFYNG	0.006128303999999999	0.6128303999999999
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006101114	0.6101114000000001
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.006101114	0.6101114000000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.006101114	0.6101114000000001
NOONAN SYNDROME 11; NS11	0.006101114	0.6101114000000001
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.006101114	0.6101114000000001
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.006101114	0.6101114000000001
6Q16 MICRODELETION SYNDROME	0.006101114	0.6101114000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.006101114	0.6101114000000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006101114	0.6101114000000001
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.006101114	0.6101114000000001
LATHOSTEROLOSIS	0.006101114	0.6101114000000001
16P11.2P12.2 MICRODELETION SYNDROME	0.006101114	0.6101114000000001
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.006101114	0.6101114000000001
MONOSOMY 22Q13.3	0.006101114	0.6101114000000001
GLASS SYNDROME	0.006101114	0.6101114000000001
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.006101114	0.6101114000000001
LAMB-SHAFFER SYNDROME	0.006101114	0.6101114000000001
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.006101114	0.6101114000000001
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.006101114	0.6101114000000001
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006101114	0.6101114000000001
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.006101114	0.6101114000000001
XQ27.3Q28 DUPLICATION SYNDROME	0.006101114	0.6101114000000001
TETRASOMY 9P	0.006101114	0.6101114000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.006101114	0.6101114000000001
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.006101114	0.6101114000000001
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.006101114	0.6101114000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006101114	0.6101114000000001
1Q21.1 MICRODELETION SYNDROME	0.006101114	0.6101114000000001
MOSAIC TRISOMY 9	0.006101114	0.6101114000000001
PHELAN-MCDERMID SYNDROME	0.006101114	0.6101114000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.006101114	0.6101114000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.006101114	0.6101114000000001
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006101114	0.6101114000000001
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006101114	0.6101114000000001
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.006097760000000001	0.6097760000000001
JEUNE SYNDROME	0.006097760000000001	0.6097760000000001
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.006097760000000001	0.6097760000000001
MOEBIUS SYNDROME; MBS	0.006097760000000001	0.6097760000000001
MOEBIUS SYNDROME	0.006097760000000001	0.6097760000000001
LARON SYNDROME	0.00573922	0.5739219999999999
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00573922	0.5739219999999999
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00573922	0.5739219999999999
ATELOSTEOGENESIS TYPE II	0.00573922	0.5739219999999999
DUPLICATION/INVERSION 15Q11	0.00573922	0.5739219999999999
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00573922	0.5739219999999999
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00558275	0.558275
CAMPOMELIA, CUMMING TYPE	0.00558275	0.558275
BASAL CELL NEVUS SYNDROME	0.00558275	0.558275
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00558275	0.558275
KLEEFSTRA SYNDROME	0.00558275	0.558275
INFANTILE SYSTEMIC HYALINOSIS	0.00558275	0.558275
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00558275	0.558275
RIN2 SYNDROME	0.00558275	0.558275
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00558275	0.558275
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00555556	0.555556
BARBER-SAY SYNDROME; BBRSAY	0.00555556	0.555556
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00555556	0.555556
NOSE, ANOMALOUS SHAPE OF	0.00555556	0.555556
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00555556	0.555556
VELOCARDIOFACIAL SYNDROME	0.00555556	0.555556
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.555556
BARBER-SAY SYNDROME	0.00555556	0.555556
OROFACIODIGITAL SYNDROME TYPE 3	0.00555556	0.555556
BEEMER-ERTBRUGGEN SYNDROME	0.00555556	0.555556
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.00555556	0.555556
ZIMMERMANN-LABAND SYNDROME	0.00555556	0.555556
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00555556	0.555556
14Q12 MICRODELETION SYNDROME	0.00555556	0.555556
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00555556	0.555556
20Q13.33 MICRODELETION SYNDROME	0.00555556	0.555556
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00555556	0.555556
RENPENNING SYNDROME 1; RENS1	0.00555556	0.555556
3M SYNDROME	0.00555556	0.555556
KAPUR-TORIELLO SYNDROME	0.00555556	0.555556
OROFACIAL CLEFT 15	0.00555556	0.555556
260150 PALANT CLEFT PALATE SYNDROME	0.00555556	0.555556
THAKKER-DONNAI SYNDROME	0.00555556	0.555556
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00555556	0.555556
CONGENITAL HYDROCEPHALUS	0.00555556	0.555556
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00555556	0.555556
OROFACIODIGITAL SYNDROME III	0.00555556	0.555556
CERNUNNOS-XLF DEFICIENCY	0.00555556	0.555556
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00555556	0.555556
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00555556	0.555556
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00555556	0.555556
CHROMOSOME 13Q14 DELETION SYNDROME	0.00555556	0.555556
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00555556	0.555556
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00555556	0.555556
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00555556	0.555556
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00555556	0.555556
DISTAL MONOSOMY 7Q36	0.00555556	0.555556
JOHNSON NEUROECTODERMAL SYNDROME	0.00555556	0.555556
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004594134000000001	0.4594134000000001
ARGININOSUCCINIC ACIDURIA	0.004594134000000001	0.4594134000000001
POTOCKI-LUPSKI SYNDROME	0.004594134000000001	0.4594134000000001
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.004594134000000001	0.4594134000000001
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004594134000000001	0.4594134000000001
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004594134000000001	0.4594134000000001
PEHO SYNDROME; PEHO	0.004594134000000001	0.4594134000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.004594134000000001	0.4594134000000001
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004594134000000001	0.4594134000000001
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004594134000000001	0.4594134000000001
TURNPENNY-FRY SYNDROME; TPFS	0.004594134000000001	0.4594134000000001
JOUBERT SYNDROME	0.004594134000000001	0.4594134000000001
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.004594134000000001	0.4594134000000001
METHYLMALONIC ACIDURIA, CBLB TYPE	0.004594134000000001	0.4594134000000001
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004594134000000001	0.4594134000000001
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.004594134000000001	0.4594134000000001
GALACTOSEMIA	0.004594134000000001	0.4594134000000001
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.4594134000000001
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004594134000000001	0.4594134000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004594134000000001	0.4594134000000001
ANGELMAN SYNDROME	0.004594134000000001	0.4594134000000001
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004594134000000001	0.4594134000000001
SHASHI-PENA SYNDROME; SHAPNS	0.004594134000000001	0.4594134000000001
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.4594134000000001
WEAVER SYNDROME	0.004594134000000001	0.4594134000000001
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.004594134000000001	0.4594134000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004594134000000001	0.4594134000000001
KABUKI SYNDROME 1	0.004594134000000001	0.4594134000000001
FOLATE MALABSORPTION, HEREDITARY	0.004594134000000001	0.4594134000000001
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004594134000000001	0.4594134000000001
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004594134000000001	0.4594134000000001
AICARDI-GOUTIERES SYNDROME 5	0.004594134000000001	0.4594134000000001
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004594134000000001	0.4594134000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004594134000000001	0.4594134000000001
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004594134000000001	0.4594134000000001
VICI SYNDROME	0.004594134000000001	0.4594134000000001
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004594134000000001	0.4594134000000001
JACOBSEN SYNDROME	0.004594134000000001	0.4594134000000001
NIEMANN-PICK DISEASE, TYPE A	0.004594134000000001	0.4594134000000001
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004594134000000001	0.4594134000000001
XQ28 (MECP2) DUPLICATION	0.004594134000000001	0.4594134000000001
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.004594134000000001	0.4594134000000001
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004594134000000001	0.4594134000000001
HYPOTONIA-CYSTINURIA SYNDROME	0.004594134000000001	0.4594134000000001
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004594134000000001	0.4594134000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.004594134000000001	0.4594134000000001
CANAVAN DISEASE	0.004594134000000001	0.4594134000000001
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004594134000000001	0.4594134000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004594134000000001	0.4594134000000001
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004594134000000001	0.4594134000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004594134000000001	0.4594134000000001
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.4594134000000001
PROPIONIC ACIDEMIA	0.004594134000000001	0.4594134000000001
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004594134000000001	0.4594134000000001
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.4235594
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004235594	0.4235594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.4235594
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.004235594	0.4235594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004235594	0.4235594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.4235594
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004235594	0.4235594
KLEEFSTRA SYNDROME 2; KLEFS2	0.004235594	0.4235594
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004235594	0.4235594
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.004235594	0.4235594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004235594	0.4235594
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.4235594
MONOSOMY 13Q34	0.004235594	0.4235594
HOLMES-GANG SYNDROME	0.004235594	0.4235594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004235594	0.4235594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.4235594
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.4235594
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.004235594	0.4235594
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004235594	0.4235594
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.4235594
CHROMOSOME 16P13.2 DELETION SYNDROME	0.004235594	0.4235594
SPINOCEREBELLAR ATAXIA TYPE 13	0.004235594	0.4235594
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004235594	0.4235594
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004235594	0.4235594
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.4235594
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004235594	0.4235594
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.4235594
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.004235594	0.4235594
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004235594	0.4235594
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.004235594	0.4235594
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.4235594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004235594	0.4235594
JABERI-ELAHI SYNDROME; JABELS	0.004235594	0.4235594
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004235594	0.4235594
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004235594	0.4235594
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.4235594
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004235594	0.4235594
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004235594	0.4235594
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.004235594	0.4235594
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.4235594
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.004235594	0.4235594
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004235594	0.4235594
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.004235594	0.4235594
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.004235594	0.4235594
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.4235594
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.004235594	0.4235594
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.4235594
BRAIN-LUNG-THYROID SYNDROME	0.004235594	0.4235594
WILSON-TURNER SYNDROME	0.004235594	0.4235594
16P13.2 MICRODELETION SYNDROME	0.004235594	0.4235594
ALG11-CDG	0.004235594	0.4235594
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.004235594	0.4235594
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.4235594
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.004235594	0.4235594
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.4235594
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.004235594	0.4235594
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.4235594
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.004235594	0.4235594
GLYCEROL KINASE DEFICIENCY; GKD	0.004235594	0.4235594
SSR4-CDG	0.004235594	0.4235594
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004235594	0.4235594
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.4235594
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004235594	0.4235594
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004235594	0.4235594
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.004235594	0.4235594
RIDDLE SYNDROME	0.004235594	0.4235594
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004235594	0.4235594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004235594	0.4235594
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.4235594
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.004235594	0.4235594
SRD5A3-CDG	0.004235594	0.4235594
SLC35A2-CDG	0.004235594	0.4235594
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004235594	0.4235594
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.004235594	0.4235594
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.004235594	0.4235594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.004235594	0.4235594
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.004235594	0.4235594
RING CHROMOSOME 12 SYNDROME	0.004235594	0.4235594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.4235594
SAY-BARBER-MILLER SYNDROME	0.004235594	0.4235594
TRANSALDOLASE DEFICIENCY	0.004235594	0.4235594
11P15.4 MICRODUPLICATION SYNDROME	0.004235594	0.4235594
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004235594	0.4235594
CEREBROFACIOARTICULAR SYNDROME	0.004235594	0.4235594
FREE SIALIC ACID STORAGE DISEASE	0.004235594	0.4235594
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.004235594	0.4235594
SYNDROMIC DIARRHEA	0.004235594	0.4235594
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.004235594	0.4235594
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.004235594	0.4235594
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.004235594	0.4235594
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004235594	0.4235594
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.004235594	0.4235594
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.4235594
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.004079124	0.4079124
FRIED SYNDROME	0.004079124	0.4079124
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004079124	0.4079124
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004079124	0.4079124
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004079124	0.4079124
THYROID HYPOPLASIA	0.004079124	0.4079124
CHROMOSOME 2Q37 DELETION SYNDROME	0.004079124	0.4079124
OGDEN SYNDROME	0.004079124	0.4079124
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004079124	0.4079124
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.4079124
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.004079124	0.4079124
PRADER-WILLI-LIKE SYNDROME	0.004079124	0.4079124
SHUKLA-VERNON SYNDROME; SHUVER	0.004079124	0.4079124
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.004079124	0.4079124
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004079124	0.4079124
KLEEFSTRA SYNDROME	0.004079124	0.4079124
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004079124	0.4079124
20Q11.2 MICRODUPLICATION SYNDROME	0.004079124	0.4079124
SIALIDOSIS TYPE 2	0.004079124	0.4079124
FAMILIAL THYROID DYSHORMONOGENESIS	0.004079124	0.4079124
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004079124	0.4079124
GENITOPATELLAR SYNDROME	0.004079124	0.4079124
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.4079124
COFFIN-SIRIS SYNDROME 4; CSS4	0.004079124	0.4079124
COFFIN-SIRIS SYNDROME 3; CSS3	0.004079124	0.4079124
TETRASOMY 5P	0.004079124	0.4079124
SIALURIA	0.004079124	0.4079124
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004079124	0.4079124
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.004079124	0.4079124
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004079124	0.4079124
DISTAL MONOSOMY 15Q	0.004079124	0.4079124
INFANTILE SIALIC ACID STORAGE DISEASE	0.004079124	0.4079124
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004079124	0.4079124
FUCOSIDOSIS	0.004079124	0.4079124
THYROID ECTOPIA	0.004079124	0.4079124
ATHYREOSIS	0.004079124	0.4079124
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004079124	0.4079124
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.4079124
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004079124	0.4079124
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004079124	0.4079124
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004079124	0.4079124
PERIPHERAL HYPOTHYROIDISM	0.004079124	0.4079124
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.004079124	0.4079124
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004079124	0.4079124
THYROID HEMIAGENESIS	0.004079124	0.4079124
MULTIPLE SULFATASE DEFICIENCY	0.004079124	0.4079124
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.004079124	0.4079124
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.40485800000000005
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.40485800000000005
STÜVE-WIEDEMANN SYNDROME	0.00404858	0.40485800000000005
SYSTEMIC SCLEROSIS	0.00404858	0.40485800000000005
GAUCHER DISEASE	0.00404858	0.40485800000000005
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.40485800000000005
RAMOS-ARROYO SYNDROME	0.00404858	0.40485800000000005
APERT SYNDROME	0.00404858	0.40485800000000005
AORTIC ARCH DEFECTS	0.00404858	0.40485800000000005
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.40485800000000005
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.40485800000000005
RING CHROMOSOME 1 SYNDROME	0.00404858	0.40485800000000005
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00404858	0.40485800000000005
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00404858	0.40485800000000005
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.40485800000000005
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.40485800000000005
INCLUSION BODY MYOSITIS	0.00404858	0.40485800000000005
GOLDENHAR SYNDROME	0.00404858	0.40485800000000005
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00404858	0.40485800000000005
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.40485800000000005
ACROCARDIOFACIAL SYNDROME	0.00404858	0.40485800000000005
FREEMAN-SHELDON SYNDROME	0.00404858	0.40485800000000005
GMS SYNDROME	0.00404858	0.40485800000000005
DERMATOMYOSITIS	0.00404858	0.40485800000000005
HYPOPHOSPHATASIA	0.00404858	0.40485800000000005
TEMPLE SYNDROME	0.00404858	0.40485800000000005
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00404858	0.40485800000000005
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.40485800000000005
CHERUBISM	0.00404858	0.40485800000000005
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.40485800000000005
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.40485800000000005
OHDO SYNDROME	0.00404858	0.40485800000000005
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00404858	0.40485800000000005
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.40485800000000005
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.40485800000000005
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00404858	0.40485800000000005
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.40485800000000005
DUBOWITZ SYNDROME	0.00404858	0.40485800000000005
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00404858	0.40485800000000005
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00404858	0.40485800000000005
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.40485800000000005
COHEN SYNDROME	0.00404858	0.40485800000000005
MARTSOLF SYNDROME	0.00404858	0.40485800000000005
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.40485800000000005
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.40485800000000005
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00404858	0.40485800000000005
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.40485800000000005
HYPOADRENOCORTICISM, FAMILIAL	0.00404858	0.40485800000000005
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.40485800000000005
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00404858	0.40485800000000005
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00404858	0.40485800000000005
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00404858	0.40485800000000005
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00404858	0.40485800000000005
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.40485800000000005
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00404858	0.40485800000000005
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.40485800000000005
NEMALINE MYOPATHY 4	0.00404858	0.40485800000000005
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.40485800000000005
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.40485800000000005
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00404858	0.40485800000000005
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.40485800000000005
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00404858	0.40485800000000005
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00404858	0.40485800000000005
PIERRE ROBIN SYNDROME	0.00404858	0.40485800000000005
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00404858	0.40485800000000005
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.40485800000000005
MYOTONIC DYSTROPHY 1	0.00404858	0.40485800000000005
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.40485800000000005
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.40485800000000005
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.40485800000000005
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.40485800000000005
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.40485800000000005
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.369004
LICHTENSTEIN SYNDROME	0.00369004	0.369004
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00369004	0.369004
KENNERKNECHT SYNDROME	0.00369004	0.369004
MCDONOUGH SYNDROME	0.00369004	0.369004
MEGAEPIPHYSEAL DWARFISM	0.00369004	0.369004
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00369004	0.369004
BETA-MANNOSIDOSIS	0.00369004	0.369004
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.369004
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.369004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.369004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00369004	0.369004
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.369004
ZECHI-CEIDE SYNDROME	0.00369004	0.369004
NEPHROSIALIDOSIS	0.00369004	0.369004
CRISS-CROSS HEART	0.00369004	0.369004
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00369004	0.369004
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.369004
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00369004	0.369004
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.369004
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.369004
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.369004
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.369004
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.369004
601095 HARROD SYNDROME	0.00369004	0.369004
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.369004
SÉZARY SYNDROME	0.00369004	0.369004
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.369004
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.369004
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.369004
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00369004	0.369004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.369004
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.369004
EPILEPSY-TELANGIECTASIA	0.00369004	0.369004
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.369004
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.369004
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.369004
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00369004	0.369004
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.369004
JUVENILE POLYPOSIS SYNDROME	0.00369004	0.369004
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.369004
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.369004
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.369004
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.369004
UROFACIAL SYNDROME	0.00369004	0.369004
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.369004
PRADER-WILLI SYNDROME	0.00369004	0.369004
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.369004
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.369004
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.369004
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.369004
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.369004
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.369004
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00369004	0.369004
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.369004
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.369004
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.369004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.369004
CROUZON DISEASE	0.00369004	0.369004
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.369004
HAIRY ELBOWS	0.00369004	0.369004
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.369004
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.369004
RING CHROMOSOME 13 SYNDROME	0.00369004	0.369004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.369004
ISOLATED BILIARY ATRESIA	0.00369004	0.369004
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00369004	0.369004
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00369004	0.369004
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.369004
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.369004
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.369004
MENTAL RETARDATION, X-LINKED 102	0.00369004	0.369004
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.369004
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00369004	0.369004
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.369004
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.369004
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.369004
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.369004
SAGLIKER SYNDROME	0.00369004	0.369004
RODRIGUES BLINDNESS	0.00369004	0.369004
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.369004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.369004
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00369004	0.369004
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00353357	0.35335700000000003
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00353357	0.35335700000000003
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00353357	0.35335700000000003
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.35335700000000003
NEURAMINIDASE DEFICIENCY	0.00353357	0.35335700000000003
CRANIODIAPHYSEAL DYSPLASIA	0.00353357	0.35335700000000003
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00353357	0.35335700000000003
PITUITARY GIGANTISM	0.00353357	0.35335700000000003
PACHYDERMOPERIOSTOSIS	0.00353357	0.35335700000000003
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.35335700000000003
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00353357	0.35335700000000003
PALLISTER-KILLIAN SYNDROME	0.00353357	0.35335700000000003
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.35335700000000003
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00353357	0.35335700000000003
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00353357	0.35335700000000003
FRYNS SYNDROME; FRNS	0.00353357	0.35335700000000003
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.35335700000000003
SANDHOFF DISEASE	0.00353357	0.35335700000000003
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.00353357	0.35335700000000003
268650 RUDIGER SYNDROME	0.00353357	0.35335700000000003
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00353357	0.35335700000000003
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.35335700000000003
2Q23.1 MICRODELETION SYNDROME	0.00353357	0.35335700000000003
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.35335700000000003
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00353357	0.35335700000000003
FRAGILE X MENTAL RETARDATION SYNDROME	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00353357	0.35335700000000003
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.35335700000000003
MUCOLIPIDOSIS III GAMMA	0.00353357	0.35335700000000003
MUCOLIPIDOSIS III ALPHA/BETA	0.00353357	0.35335700000000003
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.35335700000000003
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.35335700000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.35335700000000003
MUCOLIPIDOSIS TYPE III	0.00353357	0.35335700000000003
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00353357	0.35335700000000003
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00353357	0.35335700000000003
MORQUIO SYNDROME A	0.00353357	0.35335700000000003
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.35335700000000003
FRONTOMETAPHYSEAL DYSPLASIA	0.00353357	0.35335700000000003
ALAGILLE SYNDROME	0.00353357	0.35335700000000003
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00353357	0.35335700000000003
COFFIN-LOWRY SYNDROME; CLS	0.00353357	0.35335700000000003
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.35335700000000003
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00353357	0.35335700000000003
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00353357	0.35335700000000003
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00353357	0.35335700000000003
GALACTOSIALIDOSIS	0.00353357	0.35335700000000003
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.35335700000000003
GM1 GANGLIOSIDOSIS	0.00353357	0.35335700000000003
FRANK-TER HAAR SYNDROME; FTHS	0.00353357	0.35335700000000003
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00353357	0.35335700000000003
15Q OVERGROWTH SYNDROME	0.00353357	0.35335700000000003
HURLER-SCHEIE SYNDROME	0.00353357	0.35335700000000003
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.35335700000000003
MICROTRIPLICATION 11Q24.1	0.00353357	0.35335700000000003
GRFOMA	0.00353357	0.35335700000000003
LEUKOCYTE ADHESION DEFICIENCY	0.00353357	0.35335700000000003
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.35335700000000003
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.35335700000000003
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.35335700000000003
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.35335700000000003
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.35335700000000003
X-LINKED ACROGIGANTISM	0.00353357	0.35335700000000003
NF1-MICRODELETION SYNDROME	0.00353357	0.35335700000000003
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.25947339999999997
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0025947339999999996	0.25947339999999997
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.25947339999999997
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0025947339999999996	0.25947339999999997
RUVALCABA SYNDROME	0.0025947339999999996	0.25947339999999997
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0025947339999999996	0.25947339999999997
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.25947339999999997
AARSKOG-SCOTT SYNDROME	0.0025947339999999996	0.25947339999999997
ROBERTS SYNDROME	0.0025947339999999996	0.25947339999999997
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0025947339999999996	0.25947339999999997
TRISOMY 8Q	0.0025947339999999996	0.25947339999999997
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0025947339999999996	0.25947339999999997
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0025947339999999996	0.25947339999999997
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.25947339999999997
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.25947339999999997
OCCIPITAL HORN SYNDROME	0.0025947339999999996	0.25947339999999997
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.25947339999999997
ROIFMAN SYNDROME; RFMN	0.0025947339999999996	0.25947339999999997
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.25947339999999997
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0025947339999999996	0.25947339999999997
PALLISTER-HALL SYNDROME	0.0025947339999999996	0.25947339999999997
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025947339999999996	0.25947339999999997
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.25947339999999997
CINCA SYNDROME	0.0025947339999999996	0.25947339999999997
CODAS SYNDROME	0.0025947339999999996	0.25947339999999997
SMITH-MAGENIS SYNDROME; SMS	0.0025947339999999996	0.25947339999999997
ADAMS-OLIVER SYNDROME 1; AOS1	0.0025947339999999996	0.25947339999999997
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.25947339999999997
RAINE SYNDROME	0.0025947339999999996	0.25947339999999997
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0025947339999999996	0.25947339999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0025947339999999996	0.25947339999999997
TETRASOMY X	0.0025947339999999996	0.25947339999999997
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0025947339999999996	0.25947339999999997
DISTAL MONOSOMY 9P	0.0025947339999999996	0.25947339999999997
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.25947339999999997
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.25947339999999997
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0025947339999999996	0.25947339999999997
2Q37 MICRODELETION SYNDROME	0.0025947339999999996	0.25947339999999997
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025947339999999996	0.25947339999999997
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0025947339999999996	0.25947339999999997
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.25947339999999997
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0025947339999999996	0.25947339999999997
COWDEN SYNDROME	0.0025947339999999996	0.25947339999999997
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.25947339999999997
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0025947339999999996	0.25947339999999997
GRACILE BONE DYSPLASIA; GCLEB	0.0025947339999999996	0.25947339999999997
TEMTAMY SYNDROME; TEMTYS	0.0025947339999999996	0.25947339999999997
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0025947339999999996	0.25947339999999997
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0025947339999999996	0.25947339999999997
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0025947339999999996	0.25947339999999997
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.25947339999999997
PSEUDOAMINOPTERIN SYNDROME	0.0025947339999999996	0.25947339999999997
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.25947339999999997
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.25947339999999997
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0025947339999999996	0.25947339999999997
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0025947339999999996	0.25947339999999997
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.25947339999999997
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0025947339999999996	0.25947339999999997
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.25947339999999997
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.25947339999999997
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0025947339999999996	0.25947339999999997
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.204918
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00204918	0.204918
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00204918	0.204918
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.204918
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.204918
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.204918
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00204918	0.204918
SYNDACTYLY, TYPE V	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.204918
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.204918
HYPOCHONDROPLASIA	0.00204918	0.204918
ISOLATED BRACHYCEPHALY	0.00204918	0.204918
NON-DISTAL MONOSOMY 10Q	0.00204918	0.204918
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00204918	0.204918
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.204918
MONOSOMY 13Q14	0.00204918	0.204918
2Q37 MONOSOMY	0.00204918	0.204918
608028 THAI SYMPHALANGISM SYNDROME	0.00204918	0.204918
MULTIPLE METAPHYSEAL DYSPLASIA	0.00204918	0.204918
PSEUDOACHONDROPLASIA	0.00204918	0.204918
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.204918
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.204918
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.204918
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.204918
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.204918
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.204918
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.204918
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.204918
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.204918
SMITH-MAGENIS SYNDROME	0.00204918	0.204918
HYPERTELORISM, TEEBI TYPE	0.00204918	0.204918
SYMPHALANGISM, DISTAL	0.00204918	0.204918
GREENBERG DYSPLASIA	0.00204918	0.204918
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.204918
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.204918
SILLENCE SYNDROME	0.00204918	0.204918
ODONTOCHONDRODYSPLASIA; ODCD	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.204918
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00204918	0.204918
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.204918
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.204918
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00204918	0.204918
20P13 MICRODELETION SYNDROME	0.00204918	0.204918
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.204918
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.204918
ROIFMAN SYNDROME	0.00204918	0.204918
CHARLIE M SYNDROME	0.00204918	0.204918
THANATOPHORIC DYSPLASIA TYPE 2	0.00204918	0.204918
COOKS SYNDROME	0.00204918	0.204918
EIKEN SYNDROME	0.00204918	0.204918
LARSEN SYNDROME	0.00204918	0.204918
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.204918
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.204918
WOLCOTT-RALLISON SYNDROME	0.00204918	0.204918
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00204918	0.204918
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.204918
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.204918
FIBROCHONDROGENESIS	0.00204918	0.204918
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.204918
OROFACIODIGITAL SYNDROME I; OFD1	0.00204918	0.204918
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00204918	0.204918
FRONTORHINY	0.00204918	0.204918
GENITOPALATOCARDIAC SYNDROME	0.00204918	0.204918
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00204918	0.204918
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00204918	0.204918
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.204918
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00204918	0.204918
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00204918	0.204918
THANATOPHORIC DYSPLASIA TYPE 1	0.00204918	0.204918
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.204918
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.204918
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.204918
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.204918
RADIO-RENAL SYNDROME	0.00204918	0.204918
PERIPHERAL DYSOSTOSIS	0.00204918	0.204918
METATROPIC DYSPLASIA	0.00204918	0.204918
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.204918
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.204918
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.204918
JACOBSEN SYNDROME	0.00204918	0.204918
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00204918	0.204918
ENG-STROM SYNDROME	0.00204918	0.204918
GORLIN SYNDROME	0.00204918	0.204918
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00204918	0.204918
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.204918
HYPOCHONDROPLASIA	0.00204918	0.204918
DISTAL TRISOMY 5Q	0.00204918	0.204918
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.204918
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.204918
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.204918
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.204918
PYCNODYSOSTOSIS	0.00204918	0.204918
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.204918
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.204918
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00204918	0.204918
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.204918
LETHAL KNIEST-LIKE DYSPLASIA	0.00204918	0.204918
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.204918
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.204918
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.204918
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.204918
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.204918
ROBERTS SYNDROME; RBS	0.00204918	0.204918
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.204918
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.204918
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.204918
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.204918
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.204918
LAURENCE-MOON SYNDROME	0.00204918	0.204918
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.204918
ACRODYSOSTOSIS	0.00204918	0.204918
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.204918
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00204918	0.204918
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00204918	0.204918
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.204918
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.204918
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.204918
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00204918	0.204918
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.204918
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.204918
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.204918
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.204918
ATELOSTEOGENESIS, TYPE I; AO1	0.00204918	0.204918
SUMMITT SYNDROME	0.00204918	0.204918
CARPENTER SYNDROME	0.00204918	0.204918
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.204918
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.204918
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.204918
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.00204918	0.204918
KNIEST-LIKE DYSPLASIA, LETHAL	0.00204918	0.204918
AYME-GRIPP SYNDROME; AYGRP	0.00204918	0.204918
PFEIFFER SYNDROME	0.00204918	0.204918
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.204918
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.204918
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00204918	0.204918
THANATOPHORIC DYSPLASIA	0.00204918	0.204918
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.204918
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.204918
CAMPTOBRACHYDACTYLY	0.00204918	0.204918
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.204918
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.204918
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.204918
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.204918
GRANGE SYNDROME; GRNG	0.00204918	0.204918
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.204918
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00204918	0.204918
BRACHYDACTYLY, TYPE E	0.00204918	0.204918
ACROCALLOSAL SYNDROME; ACLS	0.00204918	0.204918
URBAN-ROGERS-MEYER SYNDROME	0.00204918	0.204918
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.204918
ADAMS-OLIVER SYNDROME	0.00204918	0.204918
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.204918
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.204918
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00204918	0.204918
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.204918
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.204918
SHORT SYNDROME	0.00204918	0.204918
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.204918
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00204918	0.204918
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.204918
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.204918
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.204918
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.204918
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.204918
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.204918
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.204918
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.204918
PROXIMAL SYMPHALANGISM	0.00204918	0.204918
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.204918
RHYNS SYNDROME; RHYNS	0.00204918	0.204918
PYCNODYSOSTOSIS	0.00204918	0.204918
LERI PLEONOSTEOSIS	0.00204918	0.204918
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.204918
OROFACIODIGITAL SYNDROME TYPE 1	0.00204918	0.204918
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00204918	0.204918
OPSISMODYSPLASIA	0.00204918	0.204918
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.204918
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.204918
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.204918
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.204918
POTOCKI-SHAFFER SYNDROME	0.00204918	0.204918
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.204918
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00204918	0.204918
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.204918
CRANIOECTODERMAL DYSPLASIA 1	0.00204918	0.204918
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.204918
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.204918
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00204918	0.204918
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.204918
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.204918
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.204918
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.204918
BANKI SYNDROME	0.00204918	0.204918
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.204918
CAMPTOBRACHYDACTYLY	0.00204918	0.204918
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.204918
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.204918
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.204918
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.204918
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.204918
CRANIOSYNOSTOSIS 2	0.00204918	0.204918
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00204918	0.204918
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.204918
SATOYOSHI SYNDROME	0.00204918	0.204918
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.204918
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.204918
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00204918	0.204918
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.204918
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00204918	0.204918
FEINGOLD SYNDROME	0.00204918	0.204918
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.204918
DESBUQUOIS DYSPLASIA 1	0.00204918	0.204918
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.204918
HEART-HAND SYNDROME TYPE 3	0.00204918	0.204918
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.204918
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00204918	0.204918
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.204918
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.204918
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.204918
ADAMS-OLIVER SYNDROME 5; AOS5	0.00204918	0.204918
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.204918
WEILL-MARCHESANI SYNDROME	0.00204918	0.204918
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.204918
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.204918
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.204918
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.204918
CAREY-FINEMAN-ZITER SYNDROME	0.00204918	0.204918
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00204918	0.204918
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00204918	0.204918
ATELOSTEOGENESIS TYPE I	0.00204918	0.204918
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.204918
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.204918
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.0545554
MEND SYNDROME	0.000545554	0.0545554
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.0545554
OXOGLUTARIC ACIDURIA	0.000545554	0.0545554
CURRY-JONES SYNDROME	0.000545554	0.0545554
3Q29 MICRODELETION SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.0545554
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.0545554
CDAGS SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.0545554
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.0545554
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.0545554
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.0545554
GRISCELLI SYNDROME	0.000545554	0.0545554
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.0545554
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.0545554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.0545554
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.0545554
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.0545554
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.0545554
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.0545554
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.0545554
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.0545554
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.0545554
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.0545554
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.0545554
HSD10 DISEASE	0.000545554	0.0545554
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000545554	0.0545554
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.0545554
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.0545554
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.0545554
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.0545554
19P13.13 MICRODELETION SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.0545554
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.0545554
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.0545554
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.0545554
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.0545554
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.0545554
WIEACKER-WOLFF SYNDROME	0.000545554	0.0545554
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.0545554
FRONTOOCULAR SYNDROME	0.000545554	0.0545554
DISTAL MONOSOMY 1Q	0.000545554	0.0545554
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.0545554
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.0545554
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.0545554
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.0545554
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.0545554
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.0545554
BAND HETEROTOPIA; BH	0.000545554	0.0545554
LOWRY-MACLEAN SYNDROME	0.000545554	0.0545554
PROPIONIC ACIDEMIA	0.000545554	0.0545554
ISOLATED PLAGIOCEPHALY	0.000545554	0.0545554
CODAS SYNDROME	0.000545554	0.0545554
YUNIS-VARON SYNDROME	0.000545554	0.0545554
NOONAN SYNDROME 2; NS2	0.000545554	0.0545554
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.0545554
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.0545554
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.0545554
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.0545554
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.0545554
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.0545554
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.0545554
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.0545554
TRISOMY 18	0.000545554	0.0545554
TARP SYNDROME; TARPS	0.000545554	0.0545554
FILIPPI SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.0545554
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
SALT-AND-PEPPER SYNDROME	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME	0.000545554	0.0545554
ISOVALERIC ACIDEMIA	0.000545554	0.0545554
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.0545554
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.0545554
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.0545554
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.0545554
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.0545554
SEVERE CANAVAN DISEASE	0.000545554	0.0545554
STT3B-CDG	0.000545554	0.0545554
WAISMAN SYNDROME; WSMN	0.000545554	0.0545554
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.0545554
TIMOTHY SYNDROME; TS	0.000545554	0.0545554
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.0545554
TRISOMY X	0.000545554	0.0545554
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.0545554
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.0545554
SARCOSINEMIA	0.000545554	0.0545554
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.0545554
STT3A-CDG	0.000545554	0.0545554
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.0545554
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.0545554
POTOCKI-SHAFFER SYNDROME	0.000545554	0.0545554
FARBER DISEASE	0.000545554	0.0545554
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.0545554
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.0545554
SALLA DISEASE	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000545554	0.0545554
RIGID SPINE SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
ALG1-CDG	0.000545554	0.0545554
GAUCHER DISEASE, TYPE II	0.000545554	0.0545554
ALG3-CDG	0.000545554	0.0545554
ALG6-CDG	0.000545554	0.0545554
PMM2-CDG	0.000545554	0.0545554
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.0545554
GRISCELLI SYNDROME TYPE 1	0.000545554	0.0545554
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.0545554
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.0545554
CLASSIC PHENYLKETONURIA	0.000545554	0.0545554
BIOTINIDASE DEFICIENCY	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.0545554
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.0545554
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.0545554
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.0545554
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.0545554
CITRULLINEMIA, CLASSIC	0.000545554	0.0545554
COACH SYNDROME	0.000545554	0.0545554
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.0545554
TAY-SACHS DISEASE	0.000545554	0.0545554
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
SCHIZENCEPHALY	0.000545554	0.0545554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.0545554
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.0545554
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000545554	0.0545554
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.0545554
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.0545554
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
ARIMA SYNDROME	0.000545554	0.0545554
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.0545554
VICI SYNDROME; VICIS	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.0545554
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.0545554
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.0545554
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.0545554
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.0545554
KETOADIPICACIDURIA	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.0545554
CEDNIK SYNDROME	0.000545554	0.0545554
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.0545554
WOLMAN DISEASE	0.000545554	0.0545554
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
HYPERPROLINEMIA, TYPE I	0.000545554	0.0545554
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.0545554
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.0545554
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.0545554
MONOSOMY 9Q22.3	0.000545554	0.0545554
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.0545554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.0545554
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.0545554
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.000545554	0.0545554
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.0545554
HARTNUP DISORDER	0.000545554	0.0545554
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.0545554
JOUBERT SYNDROME 1	0.000545554	0.0545554
LEBER CONGENITAL AMAUROSIS	0.000545554	0.0545554
CURRARINO SYNDROME	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.0545554
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.0545554
CHAR SYNDROME	0.000545554	0.0545554
PELGER-HUET ANOMALY; PHA	0.000545554	0.0545554
PRADER-WILLI SYNDROME; PWS	0.000545554	0.0545554
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.0545554
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.0545554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.0545554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.0545554
SEPTOOPTIC DYSPLASIA	0.000545554	0.0545554
PFEIFFER SYNDROME TYPE 2	0.000545554	0.0545554
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.0545554
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.0545554
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.0545554
KEUTEL SYNDROME	0.000545554	0.0545554
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.0545554
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.0545554
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.0545554
49,XXXXY SYNDROME	0.000545554	0.0545554
48,XXXY SYNDROME	0.000545554	0.0545554
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.0545554
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.0545554
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.0545554
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.0545554
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.000545554	0.0545554
DISTAL MONOSOMY 19P13.3	0.000545554	0.0545554
DISTAL MONOSOMY 6P	0.000545554	0.0545554
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.0545554
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.0545554
PALLISTER-HALL SYNDROME	0.000545554	0.0545554
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.0545554
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.0545554
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.0545554
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.0545554
AUSTRALIA ANTIGEN	0.000545554	0.0545554
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.0545554
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.0545554
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.0545554
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.0545554
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.0545554
C SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.0545554
BRESEK SYNDROME	0.000545554	0.0545554
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.0545554
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.0545554
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.0545554
CONGENITAL TOXOPLASMOSIS	0.000545554	0.0545554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.0545554
DPAGT1-CDG	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.0545554
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.0545554
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.0545554
ALSTROM SYNDROME; ALMS	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.0545554
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.0545554
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.0545554
WALKER-WARBURG SYNDROME	0.000545554	0.0545554
DIGEORGE SYNDROME; DGS	0.000545554	0.0545554
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.0545554
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.0545554
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
SULFOCYSTEINURIA	0.000545554	0.0545554
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.0545554
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.0545554
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.0545554
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.0545554
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.0545554
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.0545554
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.0545554
WAARDENBURG-SHAH SYNDROME	0.000545554	0.0545554
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.0545554
INCONTINENTIA PIGMENTI	0.000545554	0.0545554
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.0545554
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.0545554
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.0545554
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
ZEBRA BODY MYOPATHY	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.000545554	0.0545554
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.0545554
REVESZ SYNDROME	0.000545554	0.0545554
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.0545554
ROTHMUND-THOMSON SYNDROME	0.000545554	0.0545554
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.0545554
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.0545554
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.0545554
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.0545554
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.0545554
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.0545554
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.0545554
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.0545554
MEHMO SYNDROME; MEHMO	0.000545554	0.0545554
DYSTONIA-APHONIA SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.0545554
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.0545554
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.0545554
MEND SYNDROME; MEND	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.0545554
PHACE SYNDROME	0.000545554	0.0545554
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.0545554
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.0545554
COG2-CDG	0.000545554	0.0545554
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000545554	0.0545554
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.0545554
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000545554	0.0545554
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.0545554
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000545554	0.0545554
3MC SYNDROME 2	0.000545554	0.0545554
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.0545554
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
JAWAD SYNDROME	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.0545554
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000545554	0.0545554
CRANIOPHARYNGIOMA	0.000545554	0.0545554
WYBURN-MASON SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
ATELOSTEOGENESIS TYPE III	0.000545554	0.0545554
MUCOLIPIDOSIS IV; ML4	0.000545554	0.0545554
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.0545554
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.000545554	0.0545554
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.0545554
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.0545554
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.0545554
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.0545554
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.0545554
NARP SYNDROME	0.000545554	0.0545554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.0545554
ALSTRÖM SYNDROME	0.000545554	0.0545554
NETHERTON SYNDROME	0.000545554	0.0545554
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.0545554
MEDULLOBLASTOMA	0.000545554	0.0545554
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.0545554
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.0545554
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.0545554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.0545554
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.0545554
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.0545554
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.0545554
MAPLE SYRUP URINE DISEASE	0.000545554	0.0545554
12Q14 MICRODELETION SYNDROME	0.000545554	0.0545554
AICARDI-GOUTIÈRES SYNDROME	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.0545554
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.0545554
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.0545554
PELLAGRA-LIKE SYNDROME	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.0545554
LEIGH SYNDROME; LS	0.000545554	0.0545554
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.0545554
TRANSKETOLASE DEFICIENCY	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
PHACE ASSOCIATION	0.000545554	0.0545554
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.0545554
KRABBE DISEASE	0.000545554	0.0545554
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.0545554
OROTIC ACIDURIA	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.0545554
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000545554	0.0545554
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.0545554
LISSENCEPHALY 2; LIS2	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.0545554
NAVAJO NEUROHEPATOPATHY	0.000545554	0.0545554
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.0545554
ELEJALDE DISEASE	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.0545554
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.0545554
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.0545554
NETHERTON SYNDROME; NETH	0.000545554	0.0545554
8Q24.3 MICRODELETION SYNDROME	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.0545554
LIG4 SYNDROME	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.0545554
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.0545554
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.0545554
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.0545554
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000545554	0.0545554
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.0545554
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.0545554
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000545554	0.0545554
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.0545554
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.0545554
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.0545554
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000545554	0.0545554
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.0545554
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.0545554
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.0545554
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.0545554
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.0545554
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.0545554
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.0545554
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.0545554
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.0545554
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.0545554
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.0545554
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.0545554
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.0545554
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.0545554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.0545554
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.0545554
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.0545554
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.0545554
AURICULOCONDYLAR SYNDROME	0.000545554	0.0545554
SECKEL SYNDROME 8; SCKL8	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.0545554
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.0545554
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.0545554
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.0545554
XIA-GIBBS SYNDROME	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.0545554
CULLER-JONES SYNDROME; CJS	0.000545554	0.0545554
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.0545554
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.0545554
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 21	0.000545554	0.0545554
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.0545554
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.0545554
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.0545554
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.0545554
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
XQ21 MICRODELETION SYNDROME	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.0545554
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.0545554
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.0545554
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.0545554
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.0545554
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.0545554
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.0545554
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.0545554
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.0545554
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.0545554
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.0545554
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.0545554
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.0545554
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.0545554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.0545554
AYMÉ-GRIPP SYNDROME	0.000545554	0.0545554
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.0545554
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 2	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.0545554
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.0545554
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.0545554
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.0545554
PENTASOMY X	0.000545554	0.0545554
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.0545554
FUMARASE DEFICIENCY; FMRD	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000545554	0.0545554
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.0545554
EVEN-PLUS SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.0545554
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.0545554
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.0545554
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.0545554
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.0545554
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.0545554
MECKEL SYNDROME 13; MKS13	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000545554	0.0545554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.0545554
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.0545554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.0545554
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.0545554
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.0545554
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.0545554
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.0545554
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.0545554
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.0545554
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.0545554
OPTIC ATROPHY 11; OPA11	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.0545554
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.0545554
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.0545554
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.0545554
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.0545554
ZTTK SYNDROME; ZTTKS	0.000545554	0.0545554
MIRAGE SYNDROME; MIRAGE	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.0545554
JOUBERT SYNDROME 28	0.000545554	0.0545554
JOUBERT SYNDROME 27	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.0545554
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.0545554
MEIER-GORLIN SYNDROME 7	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.0545554
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.0545554
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.0545554
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.0545554
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.0545554
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.0545554
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.0545554
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.0545554
LISSENCEPHALY 8; LIS8	0.000545554	0.0545554
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.0545554
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.0545554
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.0545554
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.0545554
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.0545554
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.0545554
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.0545554
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.0545554
AU-KLINE SYNDROME; AUKS	0.000545554	0.0545554
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.0545554
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.0545554
RING CHROMOSOME 14 SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.0545554
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME 9	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000545554	0.0545554
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.0545554
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.0545554
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000545554	0.0545554
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.0545554
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.0545554
NOONAN SYNDROME 9; NS9	0.000545554	0.0545554
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.0545554
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.0545554
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.0545554
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.0545554
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.0545554
AL KAISSI SYNDROME; ALKAS	0.000545554	0.0545554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.0545554
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.0545554
SECKEL SYNDROME 9; SCKL9	0.000545554	0.0545554
JOUBERT SYNDROME 25	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.0545554
JOUBERT SYNDROME 26	0.000545554	0.0545554
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.0545554
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.0545554
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.0545554
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.0545554
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.0545554
JOUBERT SYNDROME 24	0.000545554	0.0545554
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.0545554
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.0545554
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.0545554
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.0545554
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.0545554
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.0545554
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.0545554
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.0545554
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.0545554
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.0545554
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.0545554
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.0545554
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.0545554
XP21 MICRODELETION SYNDROME	0.000545554	0.0545554
2P15P16.1 MICRODELETION SYNDROME	0.000545554	0.0545554
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.0545554
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000545554	0.0545554
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.0545554
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.0545554
20P12.3 MICRODELETION SYNDROME	0.000545554	0.0545554
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.0545554
17Q12 MICRODELETION SYNDROME	0.000545554	0.0545554
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.0545554
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
16P13.11 MICRODELETION SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 8	0.000545554	0.0545554
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.0545554
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 7	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.0545554
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.0545554
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.0545554
BILATERAL POLYMICROGYRIA	0.000545554	0.0545554
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.0545554
MEVALONIC ACIDURIA; MEVA	0.000545554	0.0545554
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.0545554
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.0545554
JOUBERT SYNDROME 6	0.000545554	0.0545554
COG4-CDG	0.000545554	0.0545554
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.0545554
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.0545554
HOLOPROSENCEPHALY 7	0.000545554	0.0545554
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.0545554
15Q14 MICRODELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.0545554
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.0545554
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.0545554
MICRO SYNDROME	0.000545554	0.0545554
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.0545554
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.0545554
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.0545554
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.0545554
8P11.2 DELETION SYNDROME	0.000545554	0.0545554
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.0545554
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.0545554
NOONAN SYNDROME 6; NS6	0.000545554	0.0545554
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.0545554
MARDEN-WALKER SYNDROME	0.000545554	0.0545554
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.0545554
RFT1-CDG	0.000545554	0.0545554
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.0545554
6Q25 MICRODELETION SYNDROME	0.000545554	0.0545554
8P23.1 MICRODELETION SYNDROME	0.000545554	0.0545554
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.0545554
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.0545554
N SYNDROME	0.000545554	0.0545554
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.0545554
MIETENS SYNDROME	0.000545554	0.0545554
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.0545554
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.0545554
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.0545554
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.0545554
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.0545554
KAGAMI-OGATA SYNDROME	0.000545554	0.0545554
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.0545554
19P13.12 MICRODELETION SYNDROME	0.000545554	0.0545554
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.0545554
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.0545554
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.0545554
CK SYNDROME	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.0545554
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.0545554
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.0545554
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.0545554
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.0545554
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.0545554
LARSEN-LIKE SYNDROME	0.000545554	0.0545554
CONGENITAL VARICELLA SYNDROME	0.000545554	0.0545554
MEVALONIC ACIDURIA	0.000545554	0.0545554
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.0545554
KAGAMI-OGATA SYNDROME	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.0545554
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.0545554
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.0545554
TARP SYNDROME	0.000545554	0.0545554
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.0545554
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.0545554
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.0545554
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.0545554
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.0545554
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.0545554
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.0545554
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.0545554
LISSENCEPHALY 1; LIS1	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.0545554
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.0545554
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.0545554
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.0545554
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.0545554
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.0545554
HEREDITARY OROTIC ACIDURIA	0.000545554	0.0545554
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.0545554
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.0545554
DE BARSY SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.0545554
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
EMANUEL SYNDROME	0.000545554	0.0545554
PERLMAN SYNDROME	0.000545554	0.0545554
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.0545554
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.0545554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.0545554
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.0545554
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.0545554
NOONAN SYNDROME 3; NS3	0.000545554	0.0545554
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.0545554
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.0545554
L1 SYNDROME	0.000545554	0.0545554
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.0545554
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.0545554
OPITZ G/BBB SYNDROME	0.000545554	0.0545554
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.0545554
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.0545554
FRIAS SYNDROME	0.000545554	0.0545554
OTOFACIOCERVICAL SYNDROME	0.000545554	0.0545554
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.0545554
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.0545554
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000545554	0.0545554
PEHO SYNDROME	0.000545554	0.0545554
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.0545554
WRINKLY SKIN SYNDROME	0.000545554	0.0545554
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.0545554
SCHINDLER DISEASE, TYPE I	0.000545554	0.0545554
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.0545554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.0545554
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.0545554
W SYNDROME	0.000545554	0.0545554
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.0545554
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.0545554
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.0545554
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.0545554
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.0545554
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.0545554
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.0545554
DYSKERATOSIS CONGENITA	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.0545554
DISTAL TRISOMY 6P	0.000545554	0.0545554
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.0545554
22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.0545554
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.0545554
TOLUENE EMBRYOPATHY	0.000545554	0.0545554
EAST SYNDROME	0.000545554	0.0545554
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.0545554
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.0545554
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.0545554
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.0545554
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.0545554
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000545554	0.0545554
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.0545554
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.0545554
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.0545554
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.0545554
DISTAL TRISOMY 18Q	0.000545554	0.0545554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000545554	0.0545554
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.0545554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.0545554
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.0545554
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.0545554
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.0545554
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.0545554
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.0545554
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.0545554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.0545554
2P21 MICRODELETION SYNDROME	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.0545554
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.0545554
MOSAIC TRISOMY 14	0.000545554	0.0545554
TRISOMY 12P	0.000545554	0.0545554
STEEL SYNDROME; STLS	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.0545554
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.0545554
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.0545554
DEXTROCARDIA	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.0545554
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.0545554
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.0545554
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.0545554
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.0545554
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.0545554
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MICROVILLUS INCLUSION DISEASE	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.0545554
LISSENCEPHALY 4	0.000545554	0.0545554
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.0545554
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.000545554	0.0545554
ICF SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.0545554
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.0545554
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.0545554
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.0545554
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.0545554
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.0545554
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.0545554
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.0545554
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.0545554
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.0545554
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.0545554
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.0545554
1Q44 MICRODELETION SYNDROME	0.000545554	0.0545554
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.0545554
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.0545554
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.0545554
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.0545554
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.0545554
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.0545554
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.0545554
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.0545554
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.0545554
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.0545554
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.0545554
HYPERTRICHOSIS CUBITI	0.000545554	0.0545554
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.0545554
JOUBERT SYNDROME 15	0.000545554	0.0545554
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.0545554
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.0545554
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.0545554
CUTIS LAXA	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.0545554
OPTIC PATHWAY GLIOMA	0.000545554	0.0545554
GERODERMA OSTEODYSPLASTICA	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.0545554
GERMAN SYNDROME	0.000545554	0.0545554
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.0545554
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME	0.000545554	0.0545554
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.0545554
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.0545554
COLE-CARPENTER SYNDROME	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.0545554
JOUBERT SYNDROME 14	0.000545554	0.0545554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000545554	0.0545554
DONNAI-BARROW SYNDROME	0.000545554	0.0545554
HOLOPROSENCEPHALY 11	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.0545554
JOUBERT SYNDROME WITH RENAL DEFECT	0.000545554	0.0545554
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000545554	0.0545554
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.0545554
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.0545554
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.0545554
HYDRANENCEPHALY	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.0545554
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.0545554
ZECHI-CEIDE SYNDROME	0.000545554	0.0545554
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.0545554
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.0545554
